Clinical Trial Update: A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating GSK1605786 for active ulcerative colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GSK1605786

Snippet

Sponsor: GlaxoSmithKline | Conditions: Colitis, Ulcerative | Phase 2 | Status: WITHDRAWN